Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1

P. T P Kaumaya, S. F. Conrad, A. M. DiGeorge, Michael Dale Lairmore

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Human T-lymphotropic virus type 1 (HTLV-I) is a retrovirus associated with adult T-cell leukemia/lymphoma, and the virus infection constitutes a growing public health problem. In a continuing effort to engineer conformationally dependent HTLV-I epitopes that elicit a protective immune response, we have examined the role and functional importance of carbohydrate moieties in specific immune recognition and antibody responses. There have been several reports of the importance of N-linked virus glycosylation in the formation of neutralizing antibodies. Residues 230-257 is predicted to encode two β-turn/loop regions at 240-244 (LYGPN), 248-257 (VPSSSSTPL) and a glycosylation site at N-244 (NVS). We have successfully engineered and synthesized the 233-253 sequence of gp46 of HTLV-1 with and without GlcNAC at Asn244. Circular dichroism spectroscopy and proton NMR showed the presence of β-turn conformation in both peptide constructs. Chimeras of the glycosylated and non-glycosylated epitope with promiscuous T-cell epitope were synthesized and shown to elicit high titered antibodies in rabbits specific for the immunogen (SC1MVF and SCSMVF) and the B cell epitope 233-253. Additionally, antibodies to the glycosylated form of the peptide recognized the HTLV-I envelope precusor in radioimmunoassay precipitation assay and react with HTLV-I whole virus preparations in ELISA.

Original languageEnglish (US)
JournalLeukemia
Volume9
Issue numberSUPPL. 1
StatePublished - 1995
Externally publishedYes

Fingerprint

Human T-lymphotropic virus 1
Glycosylation
Epitopes
Peptides
Viruses
B-Lymphocyte Epitopes
Adult T Cell Leukemia Lymphoma
T-Lymphocyte Epitopes
Antibodies
Virus Diseases
Retroviridae
Circular Dichroism
Neutralizing Antibodies
Antibody Formation
Radioimmunoassay
Protons
Magnetic Resonance Spectroscopy
Public Health
Enzyme-Linked Immunosorbent Assay
Carbohydrates

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Kaumaya, P. T. P., Conrad, S. F., DiGeorge, A. M., & Lairmore, M. D. (1995). Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1. Leukemia, 9(SUPPL. 1).

Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1. / Kaumaya, P. T P; Conrad, S. F.; DiGeorge, A. M.; Lairmore, Michael Dale.

In: Leukemia, Vol. 9, No. SUPPL. 1, 1995.

Research output: Contribution to journalArticle

Kaumaya, PTP, Conrad, SF, DiGeorge, AM & Lairmore, MD 1995, 'Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1', Leukemia, vol. 9, no. SUPPL. 1.
Kaumaya, P. T P ; Conrad, S. F. ; DiGeorge, A. M. ; Lairmore, Michael Dale. / Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1. In: Leukemia. 1995 ; Vol. 9, No. SUPPL. 1.
@article{6495b9ad7b234aee8584142a6cb7d0f7,
title = "Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1",
abstract = "Human T-lymphotropic virus type 1 (HTLV-I) is a retrovirus associated with adult T-cell leukemia/lymphoma, and the virus infection constitutes a growing public health problem. In a continuing effort to engineer conformationally dependent HTLV-I epitopes that elicit a protective immune response, we have examined the role and functional importance of carbohydrate moieties in specific immune recognition and antibody responses. There have been several reports of the importance of N-linked virus glycosylation in the formation of neutralizing antibodies. Residues 230-257 is predicted to encode two β-turn/loop regions at 240-244 (LYGPN), 248-257 (VPSSSSTPL) and a glycosylation site at N-244 (NVS). We have successfully engineered and synthesized the 233-253 sequence of gp46 of HTLV-1 with and without GlcNAC at Asn244. Circular dichroism spectroscopy and proton NMR showed the presence of β-turn conformation in both peptide constructs. Chimeras of the glycosylated and non-glycosylated epitope with promiscuous T-cell epitope were synthesized and shown to elicit high titered antibodies in rabbits specific for the immunogen (SC1MVF and SCSMVF) and the B cell epitope 233-253. Additionally, antibodies to the glycosylated form of the peptide recognized the HTLV-I envelope precusor in radioimmunoassay precipitation assay and react with HTLV-I whole virus preparations in ELISA.",
author = "Kaumaya, {P. T P} and Conrad, {S. F.} and DiGeorge, {A. M.} and Lairmore, {Michael Dale}",
year = "1995",
language = "English (US)",
volume = "9",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1

AU - Kaumaya, P. T P

AU - Conrad, S. F.

AU - DiGeorge, A. M.

AU - Lairmore, Michael Dale

PY - 1995

Y1 - 1995

N2 - Human T-lymphotropic virus type 1 (HTLV-I) is a retrovirus associated with adult T-cell leukemia/lymphoma, and the virus infection constitutes a growing public health problem. In a continuing effort to engineer conformationally dependent HTLV-I epitopes that elicit a protective immune response, we have examined the role and functional importance of carbohydrate moieties in specific immune recognition and antibody responses. There have been several reports of the importance of N-linked virus glycosylation in the formation of neutralizing antibodies. Residues 230-257 is predicted to encode two β-turn/loop regions at 240-244 (LYGPN), 248-257 (VPSSSSTPL) and a glycosylation site at N-244 (NVS). We have successfully engineered and synthesized the 233-253 sequence of gp46 of HTLV-1 with and without GlcNAC at Asn244. Circular dichroism spectroscopy and proton NMR showed the presence of β-turn conformation in both peptide constructs. Chimeras of the glycosylated and non-glycosylated epitope with promiscuous T-cell epitope were synthesized and shown to elicit high titered antibodies in rabbits specific for the immunogen (SC1MVF and SCSMVF) and the B cell epitope 233-253. Additionally, antibodies to the glycosylated form of the peptide recognized the HTLV-I envelope precusor in radioimmunoassay precipitation assay and react with HTLV-I whole virus preparations in ELISA.

AB - Human T-lymphotropic virus type 1 (HTLV-I) is a retrovirus associated with adult T-cell leukemia/lymphoma, and the virus infection constitutes a growing public health problem. In a continuing effort to engineer conformationally dependent HTLV-I epitopes that elicit a protective immune response, we have examined the role and functional importance of carbohydrate moieties in specific immune recognition and antibody responses. There have been several reports of the importance of N-linked virus glycosylation in the formation of neutralizing antibodies. Residues 230-257 is predicted to encode two β-turn/loop regions at 240-244 (LYGPN), 248-257 (VPSSSSTPL) and a glycosylation site at N-244 (NVS). We have successfully engineered and synthesized the 233-253 sequence of gp46 of HTLV-1 with and without GlcNAC at Asn244. Circular dichroism spectroscopy and proton NMR showed the presence of β-turn conformation in both peptide constructs. Chimeras of the glycosylated and non-glycosylated epitope with promiscuous T-cell epitope were synthesized and shown to elicit high titered antibodies in rabbits specific for the immunogen (SC1MVF and SCSMVF) and the B cell epitope 233-253. Additionally, antibodies to the glycosylated form of the peptide recognized the HTLV-I envelope precusor in radioimmunoassay precipitation assay and react with HTLV-I whole virus preparations in ELISA.

UR - http://www.scopus.com/inward/record.url?scp=0028841053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028841053&partnerID=8YFLogxK

M3 - Article

C2 - 7475306

AN - SCOPUS:0028841053

VL - 9

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - SUPPL. 1

ER -